Wladimir Hogenhuis
Directeur/Membre du Conseil chez REZOLUTE, INC.
Fortune : 85 002 $ au 30/04/2024
Postes actifs de Wladimir Hogenhuis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REZOLUTE, INC. | Directeur/Membre du Conseil | 02/03/2021 | - |
| Independent Dir/Board Member | 02/03/2021 | - | |
GATT Technologies BV
 GATT Technologies BV Medical SpecialtiesHealth Technology GATT Technologies BV develops a soluble surgical tape. It manufactures a polymer-based general adhesive tissue tape that is used as a surgical sealant for various surgical applications. The company was founded in August 2011 by Johan Bender and André de Lege and is headquartered in Nijmegen, the Netherlands. | Directeur/Membre du Conseil | 01/05/2020 | - |
| IHP Therapeutics, Inc. | Directeur/Membre du Conseil | - | - |
Driver Bioengineering, Inc.
 Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | 28/04/2022 | - |
| Directeur Général | 28/04/2022 | - | |
| President | 28/04/2022 | - |
Historique de carrière de Wladimir Hogenhuis
Anciens postes connus de Wladimir Hogenhuis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur des opérations | 28/09/2018 | 10/01/2020 |
| GSK PLC | Corporate Officer/Principal | 01/12/2012 | 01/09/2018 |
| Vision 2020 | Directeur/Membre du Conseil | - | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Formation de Wladimir Hogenhuis
| University of Leiden | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 8 |
| Pays-Bas | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| REZOLUTE, INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
GATT Technologies BV
GATT Technologies BV Medical SpecialtiesHealth Technology GATT Technologies BV develops a soluble surgical tape. It manufactures a polymer-based general adhesive tissue tape that is used as a surgical sealant for various surgical applications. The company was founded in August 2011 by Johan Bender and André de Lege and is headquartered in Nijmegen, the Netherlands. | Health Technology |
| IHP Therapeutics, Inc. | |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
| Vision 2020 |
- Bourse
- Insiders
- Wladimir Hogenhuis
- Expérience
